Skip to main content
. 2014 Jul 21;20(27):9154–9161. doi: 10.3748/wjg.v20.i27.9154

Table 1.

Pancreatic disease entities and the severity of pain n (%)

Diagnosis Pain
P value
Pain 0 Pain I Pain II
Pancreatic cancer 211 154 65 < 0.0001
(49.0) (35.8) (15.1)
Chronic pancreatitis 54 140 101
(18.3) (47.5) (34.2)
Serous cystadenoma 18 12 1 < 0.02
(58.0) (38.7) (3.2)
Mucinous cystadenoma 4 11 4
(21.0) (57.9) (21.0)
Non-invasive IPMN 19 20 2 0.235
(46.3) (48.8) (4.9)
Invasive IPMN 11 18 5
(32.4) (52.9) (14.7)
Low stage neuroendocrine neoplasia 9 5 0 0.565
(64.3) (35.7) (0.0)
High stage neuroendocrine neoplasia 23 13 3
(59.0) (33.3) (7.7)
AmpC 27 13 4
(61.4) (29.6) (9.1)
Total 322 246 84
(49.4) (37.7) (12.9)

IPMN: Intraductal papillary mucinous neoplasia.